Self-assembled arene ruthenium metalla-assemblies

Synthesis, characterization, and heparin-binding study of a self-assembled p-cymene-Ru(II) metallocycle based on a 4-amino-1,8-naphthalimide Tröger's base supramolecular scaffold

We report the very first example of a self-assembled p-cymene-Ru(II) metallocycle based on a green emitting 4-amino-1,8-naphthalimide Tröger's base (TBNap) supramolecular scaffold. A new cleft-shaped TBNap-derived di-4-picolyl donor was synthesized and reacted in a 2 : 2 stoichiometry ratio with a dinuclear Ru(II) acceptor (Ru-A) to generate a [2 + 2] self-assembled metallocycle (TBNap-Ru-MC) in good yield. Both TBNap and TBNap-Ru-MC showed positive solvatochromism in different solvents with varying polarities. In addition, the binding propensity of cationic TBNap-Ru-MC toward the heparin polyanion was determined using fluorescence titration studies. The initial fluorescence emission of TBNap-Ru-MC was quenched upon the gradual addition of the heparin polyanion, and the Stern-Volmer quenching constant (K_SV) was calculated to be 3.97 × 10⁵ M^-1.

Unmasking Arene Ruthenium Building Blocks

We have, like many others, contributed to the development and to the popularity of arene ruthenium assemblies. From early on, our research was driven by applications, mainly biological (therapeutic, drug delivery, DNA interactions, photodynamic therapy, imaging). For nearly 15 years, we have focused on the use of arene ruthenium building block as a tool to construct added-value objects. In this account, we want to give the basic reasons behind our choice, and uncover our most successful examples, with an emphasis on the foreseen applications.

Investigation of the Anticancer Activity of Coordination-Driven Self-AssembledTwo-Dimensional Ruthenium Metalla-Rectangle

Coordination-driven self-assembly is an effective synthetic tool for the construction of spatially and electronically tunable supramolecular coordination complexes (SCCs), which are useful in various applications. Herein, we report the synthesis of a two-dimensional discrete metalla-rectangle [(η6-p-cymene)4Ru4(C6H2O4)2(2)2](CF3SO3)4 (3) by the reaction of a dinuclear half-sandwich ruthenium (II) complex [Ru2(η6-p-cymene)2(C6H2O4)Cl2] (1) and bis-pyridyl amide linker (2) in the presence of AgO3SCF3. This cationic ruthenium metalla-rectangle (3) has been isolated as its triflate salt and characterized by analytical techniques including elemental analysis, Fourier-transform infrared spectroscopy (FT-IR), proton nuclear magnetic resonance spectroscopy (1H-NMR), carbon nuclear magnetic resonance spectroscopy (13C-NMR), 1H-1H correlation spectroscopy (COSY), 1H-1H nuclear Overhauser effect spectroscopy (NOESY), diffusion ordered spectroscopy (DOSY), and high-resolution electrospray ionization mass spectrometry (HR-ESI-MS). Significantly, the 2D cationic ruthenium metalla-rectangle showed better anticancer activity towards three different cell lines (A549, Caki-1 and Lovo) as compared with the parent ruthenium complex (1) and the commercially used drug, cisplatin.